PLANET LABS PBC (PL)

US72703X1063 - Common Stock

3.87  -0.33 (-7.86%)

After market: 3.9288 +0.06 (+1.52%)

Fundamental Rating

4

Taking everything into account, PL scores 4 out of 10 in our fundamental rating. PL was compared to 80 industry peers in the Professional Services industry. While PL has a great health rating, there are worries on its profitability. PL is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year PL has reported negative net income.
PL had a negative operating cash flow in the past year.
PL had negative earnings in each of the past 5 years.
PL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -18.73%, PL is doing worse than 85.71% of the companies in the same industry.
PL has a worse Return On Equity (-25.43%) than 80.52% of its industry peers.
Industry RankSector Rank
ROA -18.73%
ROE -25.43%
ROIC N/A
ROA(3y)-19.41%
ROA(5y)-24.83%
ROE(3y)-25.47%
ROE(5y)-50.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PL's Gross Margin of 55.99% is fine compared to the rest of the industry. PL outperforms 64.94% of its industry peers.
PL's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.27%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
PL has more shares outstanding than it did 1 year ago.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 1.99 indicates that PL is not a great score, but indicates only limited risk for bankruptcy at the moment.
PL has a Altman-Z score of 1.99. This is in the lower half of the industry: PL underperforms 67.53% of its industry peers.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.99
ROIC/WACCN/A
WACC9.23%

2.3 Liquidity

PL has a Current Ratio of 2.34. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
PL has a better Current ratio (2.34) than 80.52% of its industry peers.
A Quick Ratio of 2.34 indicates that PL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.34, PL belongs to the top of the industry, outperforming 80.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.28% over the past year.
The Revenue has grown by 12.49% in the past year. This is quite good.
The Revenue has been growing by 24.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)51.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)12.49%
Revenue growth 3Y24.93%
Revenue growth 5YN/A
Sales Q2Q%10.64%

3.2 Future

PL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.77% yearly.
The Revenue is expected to grow by 16.78% on average over the next years. This is quite good.
EPS Next Y44.61%
EPS Next 2Y32.46%
EPS Next 3Y22.77%
EPS Next 5YN/A
Revenue Next Year12.88%
Revenue Next 2Y13.49%
Revenue Next 3Y16.78%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

PL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PL's earnings are expected to grow with 22.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.46%
EPS Next 3Y22.77%

0

5. Dividend

5.1 Amount

PL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PLANET LABS PBC

NYSE:PL (12/18/2024, 7:00:00 PM)

After market: 3.9288 +0.06 (+1.52%)

3.87

-0.33 (-7.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.15B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.73%
ROE -25.43%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 55.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y44.61%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.49%
Revenue growth 3Y24.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y